Woodline Partners’s Climb Bio, Inc. Common Stock CLYM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-22,192
| Closed | -$158K | – | 724 |
|
2024
Q2 | $158K | Buy |
+22,192
| New | +$158K | ﹤0.01% | 533 |
|
2022
Q4 | – | Sell |
-226,604
| Closed | -$732K | – | 857 |
|
2022
Q3 | $732K | Sell |
226,604
-146,764
| -39% | -$474K | 0.01% | 557 |
|
2022
Q2 | $1.13M | Hold |
373,368
| – | – | 0.02% | 502 |
|
2022
Q1 | $3.13M | Hold |
373,368
| – | – | 0.05% | 304 |
|
2021
Q4 | $3.91M | Sell |
373,368
-13,856
| -4% | -$145K | 0.06% | 315 |
|
2021
Q3 | $6.96M | Buy |
+387,224
| New | +$6.96M | 0.11% | 212 |
|